Cenduit Appoints John Cline as Vice President of Client Services

CONTACT:
Chelsea Archer
SCORR Marketing
308.237.5567
[email protected]

Cenduit Appoints John Cline as Vice President of Client Services

(Durham, N.C.; September 18, 2012) – Cenduit LLC, continues to offer an unprecedented level of support for its clients with the appointment of John Cline as its Vice President of Client Services.

With more than 30 years of experience in healthcare, clinical trials management, and consulting, Cline will oversee project and account management.

According to Dr. Jogin Desai, Cenduit Chief Executive Officer, Cline will be instrumental in taking Cenduit's customer service to the next level and contributing to the company's next phase of growth.

"We are excited to have someone of John's caliber join Cenduit's leadership team.  John has a proven track record of driving growth and successfully leading teams to improved productivity and processes," Desai said. "His unique combination of operations and sales experience will serve Cenduit well as we continue to grow at a rapid pace."

A graduate of the University of Georgia, Cline said he looks forward to leading the company as it works to achieve its goals.

"I am honored to work with such a talented team," Cline said. "Cenduit is a company with clear potential and an impressive drive for customer satisfaction and growth."

In 1994, Cline founded etrials Worldwide, Inc., a company focused on clinical trial software and services. He was instrumental in taking the company public in 2006. Recently, Cline served as the Vice President of Global Field Operations at ArisGlobal.       
           
About Cenduit LLC
Cenduit provides interactive response technology (IRT) - driven services for clinical trials around the world. Cenduit's IRT solutions deliver optimized clinical supply chain management and facilitate precise control over patient randomization and drug administration to enable more efficient, compliant trials. With expert personnel located across the globe, Cenduit's unprecedented level of support currently covers more than 16,000 sites in more than 100 countries. Focus on trials, not tribulations, with Cenduit. For more information or to connect with Cenduit, visit www.cenduit.com.

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.